Healthcare companies by risk reading
Healthcare companies by risk reading: 1,214 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| Basel Medical Group Ltd BMGL | 61 | Stretched | Healthcare | Singapore | 5 / 6 | $104M |
| Euroapi SAS EAPI | 47 | Elevated | Healthcare | France | 5 / 6 | $103M |
| LENSAR Inc LNSR | 45 | Elevated | Healthcare | United States | 5 / 6 | $103M |
| Pulmonx Corp LUNG | 43 | Elevated | Healthcare | United States | 5 / 6 | $102M |
| Coeptis Therapeutics Holdings Inc COEP | 60 | Stretched | Healthcare | United States | 3 / 6 | $102M |
| Definitive Healthcare Corp - Class A DH | 78 | Stretched | Healthcare | United States | 4 / 6 | $101M |
| XLS XLS | 94 | Acute | Healthcare | Switzerland | 5 / 6 | $101M |
| Cumberland Pharmaceuticals Inc CPIX | 39 | Normal | Healthcare | United States | 4 / 6 | $100M |
| CareCloud Inc CCLD | 44 | Elevated | Healthcare | United States | 4 / 6 | $100M |
| JW (Cayman) Therapeutics Co. Ltd JNY | 45 | Elevated | Healthcare | China | 5 / 6 | $98M |
| BioPorto BIOPOR | 48 | Elevated | Healthcare | Denmark | 4 / 6 | $98M |
| Park Dental Partners Inc PARK | 46 | Elevated | Healthcare | United States | 3 / 6 | $98M |
| Abionyx Pharma SA ABNX | 91 | Acute | Healthcare | France | 5 / 6 | $97M |
| Rani Therapeutics Holdings Inc Class A RANI | 53 | Elevated | Healthcare | United States | 5 / 6 | $96M |
| Tian An Medicare Limited SMI | 41 | Elevated | Healthcare | Hong Kong | 5 / 6 | $96M |
| Eurofins-Cerep SA ALECR | 37 | Normal | Healthcare | France | 4 / 6 | $95M |
| Verrica Pharmaceuticals Inc VRCA | 28 | Normal | Healthcare | United States | 5 / 6 | $94M |
| Owens & Minor Inc ACH | 56 | Elevated | Healthcare | United States | 4 / 6 | $93M |
| Wenzhou Kangning Hospital Co. Ltd 4WK | 46 | Elevated | Healthcare | China | 4 / 6 | $92M |
| Fortress Biotech Inc FBIO | 81 | Acute | Healthcare | United States | 4 / 6 | $91M |
| Channel Therapeutics Corporation PTHS | 94 | Acute | Healthcare | United States | 4 / 6 | $90M |
| Paradigm Biopharmaceuticals Limited P86 | 36 | Normal | Healthcare | Australia | 4 / 6 | $89M |
| OSE Pharma SA OSE | 84 | Acute | Healthcare | France | 5 / 6 | $89M |
| Rallybio Corp RLYB | 38 | Normal | Healthcare | United States | 4 / 6 | $89M |
| Immucell Corp ICCC | 25 | Normal | Healthcare | United States | 5 / 6 | $89M |
| Inspira Technologies Oxy B.H.N. Ltd IINN | 63 | Stretched | Healthcare | Israel | 4 / 6 | $88M |
| Hyperfine Inc - Class A HYPR | 38 | Normal | Healthcare | United States | 5 / 6 | $87M |
| RenovoRx Inc RNXT | 46 | Elevated | Healthcare | United States | 5 / 6 | $87M |
| Lee's Pharmaceutical Holdings Limited 0950.HK | 39 | Normal | Healthcare | Hong Kong | 5 / 6 | $87M |
| ElectroCore Inc ECOR | 34 | Normal | Healthcare | United States | 5 / 6 | $85M |
| Gaush Meditech Ltd F7Y | 45 | Elevated | Healthcare | China | 5 / 6 | $85M |
| Creo Medical Group PLC CREO | 74 | Stretched | Healthcare | United Kingdom | 5 / 6 | $84M |
| Atara Biotherapeutics Inc ATRA | 28 | Normal | Healthcare | United States | 5 / 6 | $84M |
| Sera Prognostics Inc Class A SERA | 69 | Stretched | Healthcare | United States | 5 / 6 | $84M |
| Gossamer Bio Inc GOSS | 78 | Stretched | Healthcare | United States | 4 / 6 | $83M |
| Burning Rock Biotech Ltd BNR | 50 | Elevated | Healthcare | China | 5 / 6 | $83M |
| Ondine Biomedical Inc OBI | 52 | Elevated | Healthcare | Canada | 5 / 6 | $83M |
| Zhengye Biotechnology Holding Ltd ZYBT | 66 | Stretched | Healthcare | China | 5 / 6 | $82M |
| ReproCELL Incorporated 6RC | 69 | Stretched | Healthcare | Japan | 4 / 6 | $81M |
| Nexstim Oyj NXTMH | 37 | Normal | Healthcare | Finland | 5 / 6 | $80M |
| CVRx Inc CVRX | 51 | Elevated | Healthcare | United States | 5 / 6 | $79M |
| Guangdong Kanghua Healthcare Group Co., Ltd. 3689.HK | 24 | Normal | Healthcare | China | 5 / 6 | $78M |
| Brii Biosciences Limited 7SS | 76 | Stretched | Healthcare | China | 4 / 6 | $78M |
| Rapid Micro Biosystems Inc - Class A RPID | 51 | Elevated | Healthcare | United States | 5 / 6 | $76M |
| Neuraxis Inc NRXS | 73 | Stretched | Healthcare | United States | 4 / 6 | $75M |
| AnGes Inc AJW | 40 | Elevated | Healthcare | Japan | 5 / 6 | $74M |
| Outset Medical Inc OM | 56 | Elevated | Healthcare | United States | 5 / 6 | $72M |
| Kooth plc KOO | 14 | Contained | Healthcare | United Kingdom | 5 / 6 | $72M |
| Spero Therapeutics Inc SPRO | 18 | Contained | Healthcare | United States | 5 / 6 | $71M |
| Medicinova Inc MNOV | 61 | Stretched | Healthcare | United States | 4 / 6 | $71M |
| iBio Inc IBIO | 67 | Stretched | Healthcare | United States | 5 / 6 | $71M |
| Champions Oncology Inc CSBR | 50 | Elevated | Healthcare | United States | 5 / 6 | $69M |
| Cardiff Oncology Inc CRDF | 53 | Elevated | Healthcare | United States | 4 / 6 | $68M |
| Forian Inc FORA | 22 | Normal | Healthcare | United States | 4 / 6 | $68M |
| Lumos Diagnostics Holdings Ltd LDX | 49 | Elevated | Healthcare | United States | 4 / 6 | $67M |
| Maat Pharma SA MAAT | 44 | Elevated | Healthcare | France | 5 / 6 | $66M |
| Zentek Ltd ZTEK | 62 | Stretched | Healthcare | Canada | 5 / 6 | $66M |
| Nightingale Health Oyj B HEALTH | 57 | Elevated | Healthcare | Finland | 5 / 6 | $65M |
| 4BASEBIO PLC EO 1 88Q | 41 | Elevated | Healthcare | United Kingdom | 5 / 6 | $64M |
| DocCheck AG AJ91 | 35 | Normal | Healthcare | Germany | 5 / 6 | $64M |
| J Frontier Co.,Ltd. R0L | 23 | Normal | Healthcare | Japan | 5 / 6 | $64M |
| INmune Bio Inc INMB | 66 | Stretched | Healthcare | United States | 4 / 6 | $64M |
| ALGAE ALGAE | 36 | Normal | Healthcare | France | 5 / 6 | $63M |
| MindWalk Holdings Corp HYFT | 51 | Elevated | Healthcare | United States | 5 / 6 | $63M |
| hVIVO plc HVO | 55 | Elevated | Healthcare | United Kingdom | 5 / 6 | $61M |
| AgeX Therapeutics Inc SER | 51 | Elevated | Healthcare | United States | 5 / 6 | $61M |
| Heron Therapeutics Inc HRTX | 45 | Elevated | Healthcare | United States | 5 / 6 | $61M |
| LABIANA HEALTH S.A.EO-10 8RK | 32 | Normal | Healthcare | Spain | 5 / 6 | $61M |
| Austco Healthcare Ltd AHC | 16 | Contained | Healthcare | Australia | 4 / 6 | $60M |
| Apollomics Inc - Class A APLM | 62 | Stretched | Healthcare | United States | 3 / 6 | $59M |
| Myomo Inc MYO | 41 | Elevated | Healthcare | United States | 5 / 6 | $59M |
| Xilio Therapeutics Inc XLO | 33 | Normal | Healthcare | United States | 5 / 6 | $59M |
| Sensus Healthcare Inc SRTS | 45 | Elevated | Healthcare | United States | 4 / 6 | $58M |
| Shield Therapeutics plc 1JS | 41 | Elevated | Healthcare | United Kingdom | 5 / 6 | $58M |
| Senzime AB SEZI | 54 | Elevated | Healthcare | Sweden | 4 / 6 | $58M |
| Curis Inc CRIS | 39 | Normal | Healthcare | United States | 3 / 6 | $58M |
| Ikena Oncology Inc IMA | 68 | Stretched | Healthcare | United States | 4 / 6 | $58M |
| Episurf Medical AB (publ) EPIS-B | 45 | Elevated | Healthcare | Sweden | 4 / 6 | $57M |
| Envoy Medical Inc - Class A COCH | 72 | Stretched | Healthcare | United States | 5 / 6 | $56M |
| NIGHTINGALE HEALTH EO 1 7XE | 58 | Elevated | Healthcare | Finland | 5 / 6 | $56M |
| Nano X Imaging Ltd NNOX | 53 | Elevated | Healthcare | Israel | 4 / 6 | $56M |
| Sequana Medical NV SEQUA | 94 | Acute | Healthcare | Belgium | 5 / 6 | $55M |
| KLEA HOLDING ALKLH | 16 | Contained | Healthcare | France | 5 / 6 | $55M |
| Theradiag SA ALTHE | 71 | Stretched | Healthcare | France | 4 / 6 | $55M |
| Xtant Medical Holdings Inc XTNT | 22 | Normal | Healthcare | United States | 5 / 6 | $55M |
| Qilian International Holding Group Ltd - Class A BGM | 63 | Stretched | Healthcare | China | 5 / 6 | $55M |
| DarioHealth Corp DRIO | 87 | Acute | Healthcare | United States | 4 / 6 | $54M |
| One Health Group Plc OHGR | 21 | Normal | Healthcare | United Kingdom | 5 / 6 | $54M |
| Celularity Inc - Class A CELU | 77 | Stretched | Healthcare | United States | 4 / 6 | $54M |
| Nutriband Inc NTRB | 69 | Stretched | Healthcare | United States | 4 / 6 | $53M |
| Tenon Medical Inc TNON | 46 | Elevated | Healthcare | United States | 5 / 6 | $52M |
| Eyenovia Inc HYPD | 77 | Stretched | Healthcare | United States | 4 / 6 | $52M |
| NanoCarrier Co. Ltd 3NQ | 58 | Elevated | Healthcare | Japan | 4 / 6 | $52M |
| Atyr Pharma Inc ATYR | 80 | Acute | Healthcare | United States | 5 / 6 | $52M |
| Scynexis Inc SCYX | 14 | Contained | Healthcare | United States | 4 / 6 | $52M |
| Bactiguard Holding AB (publ) BACTI-B | 21 | Normal | Healthcare | Sweden | 4 / 6 | $52M |
| SomnoMed Limited RJV | 43 | Elevated | Healthcare | Australia | 4 / 6 | $51M |
| VISIOMED GROUP EO 001 7V91 | 18 | Contained | Healthcare | France | 5 / 6 | $51M |
| SMAIO SA ALSMA | 16 | Contained | Healthcare | France | 5 / 6 | $51M |
| Spectral AI Inc - Class A MDAI | 54 | Elevated | Healthcare | United States | 4 / 6 | $51M |
By sector
Industrials 1,536Technology 1,292Healthcare 1,214Consumer Cyclical 1,116Basic Materials 577Communication Services 565Real Estate 552Consumer Defensive 536Energy 356Utilities 232
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.